Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Respiratory Investigation|December 4, 2012
Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in JapanHirotsugu Kenmotsu, Yasuhisa Ohde, Takehito Shukuya, et al.
Lung Cancer (Amsterdam, Netherlands)|May 10, 2011
Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumorsKyoichi Kaira, Masakuni Serizawa, Yasuhiro Koh, et al.
International Journal of Clinical Oncology|December 20, 2012
Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimensTakaaki Tokito, Hirotsugu Kenmotsu, Reiko Watanabe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumorsTaroh Satoh, Isamu Okamoto, Masaki Miyazaki, et al.
JTO Clinical and Research Reports|August 9, 2022
The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLCHiroaki Kanemura, Hidetoshi Hayashi, Shuta Tomida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumorsKyoichi Kaira, Masahiro Endo, Masato Abe, et al.
Plos One|July 11, 2013
Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array systemMasahito Hosokawa, Hirotsugu Kenmotsu, Yasuhiro Koh, et al.
Japanese Journal of Clinical Oncology|December 14, 2024
Public assistance and survival equality in patients with EGFR mutation-positive lung cancerKiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung CancerKimio Yonesaka, Junko Tanizaki, Osamu Maenishi, et al.
JTO Clinical and Research Reports|January 17, 2024
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid CarcinomaDaisuke Hazama, Kenji Nakahama, Hiroaki Kodama, et al.
Pageof 7